Cargando…

GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance

BACKGROUND/OBJECTIVES: Fasting dyslipidemia is commonly observed in insulin resistant states and mechanistically linked to hepatic overproduction of very low density lipoprotein (VLDL). Recently, the incretin hormone glucagon-like peptide-1 (GLP-1) has been implicated in ameliorating dyslipidemia as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taher, Jennifer, Baker, Christopher L., Cuizon, Carmelle, Masoudpour, Hassan, Zhang, Rianna, Farr, Sarah, Naples, Mark, Bourdon, Celine, Pausova, Zdenka, Adeli, Khosrow
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264039/ https://www.ncbi.nlm.nih.gov/pubmed/25506548 http://dx.doi.org/10.1016/j.molmet.2014.09.005

Ejemplares similares

Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
por: Hodson, Leanne, et al.
Publicado: (2020)

GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production: Evidence for Predominance of GLP-2–Stimulated Postprandial Lipemia in Normal and Insulin-Resistant States
por: Hein, Gustavo J., et al.
Publicado: (2013)

Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol
por: Shojaee-Moradie, Fariba, et al.
Publicado: (2013)

GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
por: Abdalqadir, Nyan, et al.
Publicado: (2022)

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance
por: Mulvihill, Erin E., et al.
Publicado: (2011)

Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
por: Uehara, Kahealani, et al.
Publicado: (2022)

GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
por: Parlevliet, Edwin T., et al.
Publicado: (2012)

The therapeutic potential of GLP‐1 receptor biased agonism
por: Jones, Ben
Publicado: (2021)

GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017)

Structural analysis of the dual agonism at GLP-1R and GCGR
por: Li, Yang, et al.
Publicado: (2023)

Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
por: Marx, Nikolaus, et al.
Publicado: (2018)

GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein
por: Hoffman, Simon, et al.
Publicado: (2022)

The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism
por: Wootten, Denise, et al.
Publicado: (2016)

Farnesoid X Receptor Agonism, Acetyl‐Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of De Novo Lipogenesis in a Murine NASH Model
por: Gapp, Berangere, et al.
Publicado: (2019)

De Novo Lipogenesis Products and Endogenous Lipokines
por: Yilmaz, Mustafa, et al.
Publicado: (2016)

“Let's Stay Together”; GIP and GLP-1 dual agonism in the treatment of metabolic disease
por: DiMarchi, Richard D.
Publicado: (2018)

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review
por: Mathiesen, David S., et al.
Publicado: (2019)

Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
por: Hope, David C. D., et al.
Publicado: (2021)

Long-term Stress with Hyperglucocorticoidemia-induced Hepatic Steatosis with VLDL Overproduction Is Dependent on both 5-HT2 Receptor and 5-HT Synthesis in Liver
por: Fu, Jihua, et al.
Publicado: (2016)

Desaturation index versus isotopically measured de novo lipogenesis as an indicator of acute systemic lipogenesis
por: Harding, Scott V, et al.
Publicado: (2015)

A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice
por: Hornigold, David C., et al.
Publicado: (2018)

GLP-1R Agonism Enhances Adjustable Gastric Banding in Diet-Induced Obese Rats
por: Habegger, Kirk M., et al.
Publicado: (2013)

Expanding Roles of De Novo Lipogenesis in Breast Cancer
por: Simeone, Pasquale, et al.
Publicado: (2021)

DAXX drives de novo lipogenesis and contributes to tumorigenesis
por: Mahmud, Iqbal, et al.
Publicado: (2023)

Regulation of Cholesterol Homeostasis by Hedgehog Signaling in Osteoarthritic Cartilage
por: Ali, Shabana Amanda, et al.
Publicado: (2016)

VLDL-associated mutagenic activity.
por: Gomes, M. I., et al.
Publicado: (1982)

Complex role of autophagy in regulation of hepatic lipid and lipoprotein metabolism
por: Zamani, Mostafa, et al.
Publicado: (2017)

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist–Induced Nausea and Emesis in Preclinical Models
por: Borner, Tito, et al.
Publicado: (2021)

Direct Visualization of De novo Lipogenesis in Single Living Cells
por: Li, Junjie, et al.
Publicado: (2014)

Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat
por: Song, Kangxing, et al.
Publicado: (2014)

Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues
por: Song, Ziyi, et al.
Publicado: (2018)

FASN-dependent de novo lipogenesis is required for brain development
por: Gonzalez-Bohorquez, Daniel, et al.
Publicado: (2022)

Fructose drives de novo lipogenesis affecting metabolic health
por: Geidl-Flueck, Bettina, et al.
Publicado: (2023)

Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023)

SCFAs-Induced GLP-1 Secretion Links the Regulation of Gut Microbiome on Hepatic Lipogenesis in Chickens
por: Zhang, Jian-Mei, et al.
Publicado: (2019)

Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
por: Pickford, Phil, et al.
Publicado: (2021)

De novo lipogenesis in metabolic homeostasis: More friend than foe?
por: Solinas, Giovanni, et al.
Publicado: (2015)

Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice
por: Cordoba-Chacon, Jose, et al.
Publicado: (2015)

Retinal de novo lipogenesis coordinates neurotrophic signaling to maintain vision
por: Rajagopal, Rithwick, et al.
Publicado: (2018)

Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding
por: Low, Wee Suan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g9h5qpcokef4lqdf9a0nctejvp